Docaravimab+miromavimab
About Docaravimab+miromavimab
Docaravimab+miromavimab is a combination medicine that belongs to the class of monoclonal antibodies. It is used in post-exposure rabies prophylaxis (prevention). Rabies is a viral disease spread through contact with infected animal saliva, usually through bites, scratches, or licks on broken skin. Symptoms include pain or itching at the bite site, fever, fear of water, and sensitivity to noise, light, and air.
Docaravimab+miromavimab contains Docaravimab and Miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.
Docaravimab+miromavimab will be administered by a healthcare professional; do not self-administer. Common side effects of Docaravimab+miromavimab include injection site reactions such as pain, swelling, redness, and a low-grade fever. Most of these side effects do not require medical attention and gradually resolve over time. However, please contact your doctor if these side effects persist or worsen.
Before starting treatment with Docaravimab+miromavimab, inform your doctor if you are allergic to any of its components. Consult your doctor if you are breastfeeding or pregnant. Docaravimab+miromavimab is recommended for children and older adults only if prescribed by a doctor, as its effects are not fully established. Let your doctor know if you have any pre-existing medical conditions or liver/kidney diseases before receiving Docaravimab+miromavimab.
Uses of Docaravimab+miromavimab
• Prevention of post-exposure rabies: Docaravimab+miromavimab is used for post-exposure rabies prevention.
• Prevents clinical symptoms: Docaravimab+miromavimab helps prevent clinical symptoms and fatal progression of rabies.
Medicinal Benefits
Docaravimab+miromavimab is a combination medicine belonging to the monoclonal antibody class. It is used in post-exposure rabies prophylaxis (prevention). Docaravimab+miromavimab contains Docaravimab and Miromavimab, which bind to the rabies virus and neutralize it, providing immediate passive immunity to individuals exposed to it.
Directions for Use
Storage
Side Effects of Docaravimab+miromavimab
- Low-grade fever
- Redness
- Swelling
- Pain at the injection site
Drug Warnings
Before starting treatment with Docaravimab+miromavimab, inform your doctor if you are allergic to any of its active components. Also, discuss all your health conditions and the medications you are taking with your doctor to avoid potential interactions. Inform your doctor before receiving Docaravimab+miromavimab if you are pregnant, planning to become pregnant, or breastfeeding. Additionally, caution is needed when giving this treatment to children or older adults, only if advised by a medical professional. Be careful if combining Docaravimab+miromavimab with other medications or vaccines. Therefore, always consult a doctor before starting Docaravimab+miromavimab.
Drug Interactions
Drug-Drug Interaction: No interactions found.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: No interactions found.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorThere is no evidence that alcohol affects the medication's effectiveness. Please consult your doctor about the safety of consuming alcohol with Docaravimab+miromavimab.
Pregnancy
consult your doctorBefore receiving Docaravimab+miromavimab, consult your doctor, as limited information is available for the use of Docaravimab+miromavimab in pregnant women.
Breast Feeding
consult your doctorPlease consult your doctor if you are a breastfeeding mother, as limited information is available for the use of Docaravimab+miromavimab in breastfeeding mothers.
Driving
consult your doctorIt is unclear whether Docaravimab+miromavimab affects your ability to drive. Refrain from driving if you suspect any difficulty.
Liver
consult your doctorThere is limited information available on the use of Docaravimab+miromavimab in individuals with liver problems. You are recommended to consult a doctor for further guidance.
Kidney
consult your doctorThere is limited information available on the use of Docaravimab+miromavimab in individuals with kidney problems. You are recommended to consult a doctor for further guidance.
Children
consult your doctorPlease consult your doctor before administering Docaravimab+miromavimab to your child, as there is limited information available.
Habit Forming
Diet & Lifestyle Advise
- Avoid stray animals and wildlife.
- Vaccinate pets regularly.
- Apply an iodine-containing cream to avoid irritants.
- Avoid covering the wound with dressings or bandages.
- Clean wounds with soap and water properly.
- Maintain a healthy lifestyle and avoid processed food or sugary foods.
Special Advise
Patients Concern
Disease/Condition Glossary
Rabies: It is a viral disease caused by the rabies virus. It is primarily transmitted through bites or scratches from infected animals, especially dogs. It has two forms: furious rabies through hyperactivity and hallucinations, and paralytic rabies. Symptoms include fever, pain at the bite site, hydrophobia (fear of water), hallucinations, and muscle paralysis. Rabies is fatal once clinical symptoms appear, but it can be prevented with prompt post-exposure prophylaxis (PEP), which includes wound washing, rabies vaccination, and if needed, rabies immunoglobulin (RIG).
FAQs
Docaravimab+miromavimab is used in post-exposure rabies prophylaxis (prevention).
Docaravimab+miromavimab contains Docaravimab and miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.
Docaravimab+miromavimab causes side effects such as injection site reactions like pain, redness, swelling, and low-grade fever. Therefore, contact a doctor if these side effects persist or worsen.
No, Docaravimab+miromavimab is not habit-forming. You are advised to talk to a doctor before completely stopping the treatment regimen or if you have any concerns.
Docaravimab+miromavimab is stored in temperatures between 2°C and 8°C. Protect from light. Do not freeze. Keep out of reach of children.
Docaravimab+miromavimab is a parenteral therapy, administered by a healthcare professional. The appropriate dose is carefully determined and given based on individual patient needs. Using more than the recommended dose is not recommended, as it can increase the risk of serious side effects.
